Analysis of the relapse risk by qualitative BM PCR for NPM-ALK, histologic subtype, and clinical risk features of 80 analyzed patients
| Variable . | Univariate analysis . | Multivariate analysis . | ||||
|---|---|---|---|---|---|---|
| Relative risk of relapse . | 95% confidence interval . | P . | Relative risk of relapse . | 95% confidence interval . | P . | |
| BM NPM-ALK positive | 5.71 | 2.08-15.72 | .001 | 3.47 | 1.14-10.57 | .028 |
| Histologic subtype: not common | 6.59 | 2.19-19.83 | .001 | 3.95 | 1.24-12.61 | .02 |
| Clinical risk features* | 3.91 | 1.44-10.6 | .007 | 1.88 | 0.64-5.57 | .25 |
| Variable . | Univariate analysis . | Multivariate analysis . | ||||
|---|---|---|---|---|---|---|
| Relative risk of relapse . | 95% confidence interval . | P . | Relative risk of relapse . | 95% confidence interval . | P . | |
| BM NPM-ALK positive | 5.71 | 2.08-15.72 | .001 | 3.47 | 1.14-10.57 | .028 |
| Histologic subtype: not common | 6.59 | 2.19-19.83 | .001 | 3.95 | 1.24-12.61 | .02 |
| Clinical risk features* | 3.91 | 1.44-10.6 | .007 | 1.88 | 0.64-5.57 | .25 |
BM indicates bone marrow.
Clinical risk features: involvement of skin, mediastinum, liver, spleen, or lung.